secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001104659-24-058018
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Q1 revenue $404.4M (+20% YoY), net income $14.8M (+13%), EPS $0.31
--------------------------------------------------------------------------

- Total revenue $404.4M (+20% YoY); net income attributable $14.8M (+13%); diluted EPS $0.31 (+11%).
- Adjusted EBITDA $42.2M (+42% YoY); full-year 2024 guidance reaffirmed: revenue $1.65-1.85B, adj. EBITDA $165-185M.
- Completed largest acquisition (CFC) on Mar 31 and acquired PCCCV (~26K Medicaid members) on Mar 29.
- Organic membership growth 10% YTD; total lives ~1M; full-risk capitation expected ~60% of total capitation revenue as of Apr 1.
- Opened two new de novo clinics in Nevada in April.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465924058018/0001104659-24-058018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465924058018/tm2413600d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-058018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer